Deborah Baron to Treatment Outcome
This is a "connection" page, showing publications Deborah Baron has written about Treatment Outcome.
Connection Strength
0,032
-
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
Score: 0,032